Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility

Neurogastroenterology and Motility

Volumn 28, Issue 8, 2016, Pages 1241-1251

  Dalziel, J E ^a   Young, W ^a   Bercik, P ^b   Spencer, N J ^c   Ryan, L J ^a   Dunstan, K E ^a   Lloyd West, C M ^a   Gopal, P K ^d,g   Haggarty, N W ^d   Roy, N C ^a,e,f  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b MCMASTER UNIVERSITY   (Canada)

^c FLINDERS UNIVERSITY   (Australia)

^d FONTERRA RESEARCH CENTRE   (New Zealand)

^e MASSEY UNIVERSITY   (New Zealand)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

colon transit; constipation; gastrointestinal transit; loperamide; prucalopride

Indexed keywords

LOPERAMIDE; PRUCALOPRIDE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; COLON; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL TRANSIT; INTESTINE TRANSIT TIME; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOGRAPHY; RAT; SMALL INTESTINE; STOMACH; STOMACH EMPTYING; URINE VOLUME;

EID: 84978919898     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12824     Document Type: Article

References (51)

1. O'Mahony D, O'Leary P, Quigley EMM. Aging and intestinal motility: a review of factors that affect intestinal motility in the aged. Drugs Aging 2002; 19: 515–27.
2. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 2008; 8: art. no. 5.
3. Abalo R, Chen C, Vera G, Fichna J, Thakur GA, López-Pérez AE,Makriyannis A, Martín-Fontelles MI et al. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat. Neurogastroenterol Motil 2015; 27: 1721–35.
4. Turiiski VI, Krustev AD, Sirakov VN, Getova DP. In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract. Eur J Pharmacol 2004; 498: 233–9.
5. Vegezzi G, Al Harraq Z, Levandis G, Cerri S, Blandini F, Gnudi G, Miduri F, Blandizzi C et al. Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: comparative study with conventional in vivo techniques in the rat. J Pharmacol Toxicol Methods 2014; 70: 163–9.
6. Reed DE, Pigrau M, Lu J, Moayyedi P, Collins SM, Bercik P. Bead study: a novel method to measure gastrointestinal transit in mice. Neurogastroenterol Motil 2014; 26: 1663–8.
7. Myagmarjalbuu B, Moon MJ, Heo SH, Jeong SI, Park JS, Jun JY, Jeong YY, Kang HK et al. Establishment of a protocol for determining gastrointestinal transit time in mice using barium and radiopaque markers. Korean J Radiol 2013; 14: 45–50.
8. Morley JE. Constipation and irritable bowel syndrome in the elderly. Clin Geriatr Med 2007; 23: 823–32.
9. Roque MV, Bouras EP. Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging 2015; 10: 919–30.
10. Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, Linden D, Cima RR et al. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil 2009; 21: 746–e46.
11. Gomes OA, De Souza RR, Liberti EA. A preliminary investigation of the effects of aging on the nerve cell number in the myenteric ganglia of the human colon. Gerontology 1997; 43: 210–7.
12. Montesinos RN, Moulari B, Gromand J, Beduneau A, Lamprecht A, Pellequer Y. Coadministration of p-glycoprotein modulators on loperamide pharmacokinetics and brain distribution. Drug Metab Dispos 2014; 42: 700–6.
13. Chen W, Chung HH, Cheng JT. Opiate-induced constipation related to activation of small intestine opioid μ2-receptors. World J Gastroenterol 2012; 18: 1391–6.
14. Lee HY, Kim JH, Jeung HW, Lee CU, Kim DS, Li B et al. Effects of Ficus carica paste on loperamide-induced constipation in rats. Food Chem Toxicol 2012; 50: 895–902.
15. Neri F, Cavallari G, Tsivian M, Bianchi E, Aldini R, Cevenini M, Guidetti E, Piras GL et al. Effect of colic vein ligature in rats with loperamide-induced constipation. J Biomed Biotechnol 2012; ID896162: 1–5.
16. Jeon JR, Choi JH. Lactic acid fermentation of germinated barley fiber and proliferative function of colonic epithelial cells in loperamide-induced rats. J Med Food 2010; 13: 950–60.
17. Beattie DT, Armstrong SR, Vickery RG, Tsuruda PR, Campbell CB, Richardson C, McCullough JL, Daniels O et al. The pharmacology of TD-8954, a potent and selective 5-HT4 receptor agonist with gastrointestinal prokinetic properties. Front Pharmacol 2011; 2: 1–13.
18. Camilleri M. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome. Clin Pharmacol Ther 2012; 91: 44–59.
19. Park SJ, Choi EJ, Yoon YH, Park H. The effects of prucalopride on postoperative ileus in guinea pigs. Yonsei Med J 2013; 54: 845–53.
20. Qi HB, Luo JY, Liu X. Effect of enterokinetic prucalopride on intestinal motility in fast rats. World J Gastroenterol 2003; 9: 2065–7.
21. Tack J. Prucalopride: a new drug for the treatment of chronic constipation. Expert Rev Gastroenterol Hepatol 2009; 3: 337–43.
22. 4) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol 2010; 3: 49–56.
23. Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, Prins NH, Schuurkes JAJ. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 2001; 423: 71–83.
24. Wintola OA, Sunmonu TO, Afolayan AJ. The effect of Aloe ferox Mill. In the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol 2010; 10: 95.
25. Dalziel JE, Young W, Bercik P, Spencer NJ, Ryan LJ, Dunstan KE, Burton SE, Peters JS et al. Tracking gastrointestinal transit in pharmacological models of chronic dysmotility in aged rats. Australasian Neurogastroenterology & Motility Association Meeting, 2015, Adelaide, Australia.
26. 4 receptor. Eur J Nucl Med Mol Imaging Res 2013; 3: 1–13.
27. Therapeutic Goods Administration. Australian Public Assessment Report for Prucalopride. Woden, ACT, Australia: Australian Government, Department of Health and Aging, Therapeutic Goods Administration, 2011.
28. Jang SF, Goins BA, Phillips WT, Santoyo C, Rice-Ficht A, McConville JT. Size discrimination in rat and mouse gastric emptying. Biopharm Drug Dispos 2013; 34: 107–24.
29. Saphier S, Rosner A, Brandeis R, Karton Y. Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imagining. Int J Pharm 2010; 388: 190–5.
30. Pham AC, Nguyen TH, Nowell CJ, Graham B, Boyd BJ. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging. Drug Deliv Transl Res 2015; 5: 566–74.
31. Torjman MC, Joseph JI, Munsick C, Morishita M, Grunwald Z. Effects of Isoflurane on gastrointestinal motility after brief exposure in rats. Int J Pharm 2005; 294: 65–71.
32. Munakata A, Iwane S, Todate M, Nakaji S, Sugawara K. Effects of dietary fiber on gastrointestinal transit time, fecal properties and fat absorption in rats. Tohoku J Exp Med 1995; 176: 227–38.
33. Enck P, Merlin V, Erckenbrecht JF, Wienbeck M. Stress effects on gastrointestinal transit in the rat. Gut 1989; 30: 455–9.
34. Varga F. Transit time changes with age in the gastrointestinal tract of the rat. Digestion 1976; 14: 319–24.
35. Horiuchi A, Tanaka N, Sakai R, Kawamata Y. Effect of age and elemental diets on gastric emptying in rats. J Gastroenterol Hepatol Res 2014; 3: 1340–3.
36. Smits GJM, Lefebvre RA. Influence of aging on gastric emptying of liquids, small intestine transit, and fecal output in rats. Exp Gerontol 1996; 31: 589–96.
37. Phillips RJ, Powley TL. Innervation of the gastrointestinal tract: patterns of aging. Auton Neurosci 2007; 136: 1–19.
38. Cowen T, Johnson RJR, Soubeyre V, Santer RM. Restricted diet rescues rat enteric motor neurones from age related cell death. Gut 2000; 47: 653–60.
39. Madsen JL. Effects of gender, age, and body mass index on gastrointestinal transit times. Dig Dis Sci 1992; 37: 1548–53.
40. Yeomans MR, Gray RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002; 26: 713–28.
41. Ruppin H. Review: loperamide–a potent antidiarrhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther 1987; 1: 179–90.
42. Leppert W. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Design Dev Ther 2015; 9: 2215–31.
43. Bueno L, Fioramonti J. Action of opiates on gastrointestinal function. Baillieres Clin Gastroenterol 1988; 2: 123–39.
44. Williams CL, Bihm CC, Rosenfeld GC, Burks TF. Morphine tolerance and dependence in the rat intestine in vivo. J Pharmacol Exp Ther 1997; 280: 656–63.
45. De Maeyer JH, Schuurkes JAJ, Lefebvre RA. Selective desensitization of the 5-HT 4 receptor-mediated response in pig atrium but not in stomach. Br J Pharmacol 2009; 156: 362–76.
46. De Maeyer JH, Lefebvre RA, Schuurkes JAJ. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil 2008; 20: 99–112.
47. De Winter BY, Boeckxstaens GE, De Man JG, Moreels TG, Schuurkes JAJ, Petters TL, Herman AG, Pelckmans PA. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. Gut 1999; 45: 713–8.
48. 4 agonist, prucalopride, in healthy humans. Gut 1999; 44: 682–6.
49. Kessing BF, Smout AJPM, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neurogastroenterol Motil 2014; 26: 1079–86.
50. Costa M, Dodds KN, Wiklendt L, Spencer NJ, Brookes SJH, Dinning PG. Neurogenic and myogenic motor activity in the colon of the guinea pig, mouse, rabbit, and rat. Am J Physiol Gastrointest Liver Physiol 2013; 305: G749–59.
51. 4 receptors in colonic motor patterns in rats. Neurogastroenterol Motil 2015; 27: 914–28.